Day: February 10, 2025

COOTAMUNDRA, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Australian Oilseeds Holdings Limited, a Cayman Islands exempted company (the “Company”) (NASDAQ: COOT) today announced financial results for its first quarter fiscal 2025 ended September 30, 2024. First Quarter Fiscal 2025 Financial Highlights Compared to Prior YearSales revenue increased 6.1% to A$10.4 million due to strong demand for the Company’s cold pressed canola oil.Retail oil revenue increased 59.9% to A$5.7 million due to expanded distribution in leading retailers in Australia along with the addition of several new SKUs.Net loss of A$0.6 million compared to net income of A$1.4 million, reflecting changes to sales mix along with the timing of planned investments in brand and marketing to support our GEO products.Cash flow from operations improved to A$0.6...

REDWOOD CITY, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, today announced five poster presentations and an oral presentation of briquilimab data at the AAAAI 2025 Annual Meeting, being held February 28 – March 3, 2025, in San Diego, CA. The oral presentation and one of the poster presentations will include additional follow-up from patients included in the Company’s January 8th, 2025, disclosure of preliminary data from the Phase 1b/2a BEACON trial evaluating briquilimab in CSU. Details of the presentations are as follows: Abstract...

Total new customer application volume in January 2025 increased 130% year-over-year, driving the highest level of January originations, with total originations up 44% year-over-year Monthly growth trends accelerated in January 2025, compared to December 2024 Indicators of profitability for January 2025 are encouraging with 105% increase in FlexShopper.com gross margin dollars, a 34% year-over-year reduction in marketplace marketing cost per new customer, and stable asset quality BOCA RATON, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) — FlexShopper, Inc. (Nasdaq: FPAY), a prominent national online lease-to-own retailer and payment solutions provider, today announced another strong operating month for January 2025. Positive momentum reflects the successful transformation underway as a result of FlexShopper’s direct-to-consumer (DTC) and...

WORCESTER, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced the closing of its previously announced public offering, for the issuance and sale of an aggregate of 2,657,807 shares of its common stock (or common stock equivalents in lieu thereof), Series C-1 warrants to purchase up to 2,657,807 shares of common stock and Series C-2 warrants to purchase up to 2,657,807 shares of common stock, at a combined public offering price of $3.01 per share (or per common stock equivalent in lieu thereof) and accompanying warrants. The warrants have an exercise price of $3.01 per share and will be exercisable...

BRAINTREE, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 6,103,289 shares of the Company’s common stock at a purchase price of $2.13 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered short-term series I preferred investment options. The short-term series I preferred investment options to purchase up to 12,206,578 shares of common stock have an exercise price of $2.13 per share and will be exercisable for a period of two years beginning on the later of (i) the effective date of the increase of the Company’s authorized shares of common stock following stockholder approval and (ii)...

Naples, FL, Feb. 10, 2025 (GLOBE NEWSWIRE) — Music Licensing, Inc. (OTC: SONG) (OTC: SONGD), a leader in the music rights and intellectual property sector, is pleased to announce that its wholly owned subsidiary, Pro Music Rights (PMR), has been officially recognized in the Federal Register of the United States of America as a Performing Rights Organization (PRO). This landmark recognition reinforces Pro Music Rights’ position as a key player in the U.S. music licensing ecosystem, joining the ranks of other established PROs responsible for ensuring that music creators receive fair compensation for the public performance of their works. This official acknowledgment represents a pivotal achievement for Music Licensing, Inc. (OTC: SONG) (OTC: SONGD) and its shareholders, as it validates Pro Music Rights’ authority in...

Long-Time Board Member Mary Lou Kelley Announces Retirement FORT WAYNE, Ind., Feb. 10, 2025 (GLOBE NEWSWIRE) — Vera Bradley (NASDAQ: VRA) (the “Company”) today announced the appointment of Andrew Meslow, former CEO of L Brands and Bath and Body Works, to the Company’s Board of Directors (the “Board”). Mr. Meslow joins the Board most recently from L Brands and Bath and Body Works, where he was CEO. Prior to becoming CEO, Andrew held the role of COO at Bath & Body Works, leading several functional areas of the business, including finance, merchandise planning, store operations and the direct channel. He joined L Brands in 2003, working in roles at Victoria’s Secret and the corporate group before moving to Bath & Body Works in 2005 as executive vice president and chief financial officer. Prior to joining L Brands, Andrew...

        Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to amezalpat (TPST-1120), an oral, small molecule, selective PPAR⍺ antagonist for the treatment of patients with hepatocellular carcinoma (HCC). “We are thrilled to receive Fast Track designation from the FDA,” said Sam Whiting, M.D., Ph.D., chief medical officer and head of R&D of Tempest. “This designation, following the...

TAMPA, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ:LMFA) (“LM Funding” or the “Company”), a cryptocurrency mining and technology-based specialty finance company, today announced that Bruce M. Rodgers, Chairman and CEO, has been invited to present at the “Digital Assets 2025: To Bitcoin and Beyond,” virtual conference hosted by Maxim Group LLC (“Maxim”) on Wednesday, February 12th 2025 at 8:30 AM EST. Matthew Galinko, Research Analyst at Maxim, will sit down with companies in the digital asset ecosystem, including, Bitcoin miners, equipment providers, and corporate adopters of crypto as a treasury strategy, to discuss the evolution of the industry and its prospects in 2025 with regulatory changes expected in the months ahead. The conference will be live on M-Vest. To attend, sign up to become an M-Vest...